-
Product Insights
NewHepatocyte Growth Factor Receptor – Drugs In Development, 2024
The Hepatocyte Growth Factor Receptor pipeline drugs market research report outlays comprehensive information on the Hepatocyte Growth Factor Receptor targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Central Nervous System, Musculoskeletal Disorders, and Ophthalmology which include indications of Non-Small Cell Lung Cancer, Solid Tumor, Dementia, Anxiety Disorders, Fibrosis, Ophthalmology, and Keratitis. It also reviews key players...
-
Product Insights
NewReceptor Type Tyrosine Protein Kinase FLT3 – Drugs In Development, 2024
The Receptor Type Tyrosine Protein Kinase FLT3 pipeline drugs market research report outlays comprehensive information on the Receptor Type Tyrosine Protein Kinase FLT3 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Respiratory, Genetic Disorders, and Non Malignant Disorders which include indications of Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia), Solid Tumor, Idiopathic Pulmonary Fibrosis, Interstitial Lung...
-
Product Insights
NewSerine/Threonine Protein Kinase mTOR – Drugs In Development, 2024
The Serine/Threonine Protein Kinase mTOR pipeline drugs market research report outlays comprehensive information on the Serine/Threonine Protein Kinase mTOR targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Central Nervous System, Respiratory, and Immunology which include indications of Solid Tumor, Ovarian Cancer, Epilepsy, Parkinson's Disease, Idiopathic Pulmonary Fibrosis, Viral Respiratory Tract Infection, Immunology, and Autoimmune Disorders. It...
-
Product Insights
NewCystic Fibrosis Transmembrane Conductance Regulator – Drugs In Development, 2024
The Cystic Fibrosis Transmembrane Conductance Regulator pipeline drugs market research report outlays comprehensive information on the Cystic Fibrosis Transmembrane Conductance Regulator targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Respiratory, Gastrointestinal, Genetic Disorders, and Ophthalmology which include indications of Cystic Fibrosis, Diarrhea, Infectious Diarrhea, Polycystic Kidney Disease, Duchenne Muscular Dystrophy, Keratoconjunctivitis Sicca (Dry Eye), and Retinitis Pigmentosa...
-
Product Insights
NewKappa Type Opioid Receptor – Drugs In Development, 2024
The Kappa Type Opioid Receptor pipeline drugs market research report outlays comprehensive information on the Kappa Type Opioid Receptor targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Central Nervous System, Dermatology, Toxicology, and Gastrointestinal which include indications of Pain, Opium (Opioid) Addiction, Pruritus, Uremic (Renal) Pruritus, Acute Opioid Overdosage, Drug Overdose, Irritable Bowel Syndrome, and Diarrhea. It...
-
Product Insights
NewSodium Dependent Dopamine Transporter – Drugs In Development, 2024
The Sodium Dependent Dopamine Transporter pipeline drugs market research report outlays comprehensive information on the Sodium Dependent Dopamine Transporter targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Central Nervous System, Women's Health, Metabolic Disorders, and Genetic Disorders which include indications of Attention Deficit Hyperactivity Disorder (ADHD), Post-Traumatic Stress Disorder (PTSD), Female Sexual Dysfunction, Female Hypoactive Sexual Desire...
-
Product Insights
NewBeta 2 Adrenergic Receptor – Drugs In Development, 2024
The Beta 2 Adrenergic Receptor pipeline drugs market research report outlays comprehensive information on the Beta 2 Adrenergic Receptor targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Respiratory, Ophthalmology, Immunology, and Cardiovascular which include indications of Asthma, Chronic Obstructive Pulmonary Disease (COPD), Ocular Hypertension, Open-Angle Glaucoma, Anaphylaxis, Allergies, Congestive Heart Failure (Heart Failure), and Hypertension. It also...
-
Product Insights
NewAlpha Synuclein – Drugs In Development, 2024
The Alpha Synuclein pipeline drugs market research report outlays comprehensive information on the Alpha Synuclein targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Central Nervous System, Metabolic Disorders, Cardiovascular, and Gastrointestinal which include indications of Parkinson's Disease, Multiple System Atrophy (MSA or Shy-Drager Syndrome or Multi-System Degeneration), Type 2 Diabetes, Amyloidosis, Myocardial Infarction, Ischemia, and Constipation. It...
-
Product Insights
NewAdenosine Monophosphate Activated Protein Kinase – Drugs In Development, 2024
The Adenosine Monophosphate Activated Protein Kinase pipeline drugs market research report outlays comprehensive information on the Adenosine Monophosphate Activated Protein Kinase targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Metabolic Disorders, Cardiovascular, Oncology, and Gastrointestinal which include indications of Type 2 Diabetes, Obesity, Congestive Heart Failure (Heart Failure), Diastolic Heart Failure (HFpEF), Unspecified Cancer, Triple-Negative Breast Cancer...
-
Product Insights
NewSodium Channel Protein Type 9 Subunit Alpha – Drugs In Development, 2024
The Sodium Channel Protein Type 9 Subunit Alpha pipeline drugs market research report outlays comprehensive information on the Sodium Channel Protein Type 9 Subunit Alpha targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Central Nervous System, Toxicology, Genetic Disorders, and Dermatology which include indications of Pain, Post-Operative Pain, Chemotherapy Induced Peripheral Neuropathy, Erythromelalgia, and Pruritus. It also...